12:00 AM
Aug 31, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Gardasil: Post-marketing study data

Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J.
sanofi-aventis Group (Euronext:SAN; NYSE:SNY), Paris, France
Product: Gardasil ( Silgard)
Business: Infectious
Molecular target: Not applicable
Description: Human papillomavirus (HPV) types 6, 11, 16 and 18 recombinant...

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >